Salt Lake City, UT – Health Catalyst, Inc., a data analytics company traded on NASDAQ, held its Q3 2024 Earnings Conference Call on November 6, 2024. The call featured key company executives discussing the financial performance for the third quarter of 2024.

Among the participants in the conference call were Jack Knight, the Vice President of Investor Relations, Dan Burton, the CEO, Dan LeSueur, the COO, and Jason Alger, the CFO. They were joined by various analysts from firms such as William Blair, Piper Sandler, and Barclays Bank, to name a few.

The call opened with an introduction by Jack Knight, providing an overview of Health Catalyst’s performance in the third quarter of 2024, which concluded on September 30th. He directed listeners to the company’s press release and SEC filings for detailed information on their results.

During the call, the executives made forward-looking statements in accordance with the Safe Harbor provisions, outlining their growth prospects for the remainder of 2024 and the full year of 2025. The company emphasized its commitment to delivering value to investors and stakeholders through strategic initiatives and financial projections.

In a post-call Q&A session, participants had the opportunity to pose questions to the executives, seeking clarification on various aspects of the company’s performance and future plans. Health Catalyst’s leadership provided insights on industry trends, competitive positioning, and operational strategies moving forward.

Overall, the Health Catalyst Q3 2024 Earnings Conference Call offered investors and analysts a comprehensive overview of the company’s financial health and strategic direction. The executives’ transparent communication and detailed analysis of the results reinforced confidence in Health Catalyst’s ability to navigate the evolving market landscape and deliver value to shareholders.